Bristol-Myers Squibb Company
BMY
$56.45
$0.781.40%
NYSE
Recommendation
Dividend Power Score
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
P/E (TTM)
EPS (TTM)
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | 2.68B | 1.09B | 2.20B | 1.31B | 2.46B |
| Total Depreciation and Amortization | 611.00M | 1.02B | 1.05B | 990.00M | 1.01B |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 650.00M | 1.52B | 5.00M | 1.60B | 356.00M |
| Change in Net Operating Assets | -2.83B | -1.65B | 3.06B | 15.00M | -1.87B |
| Cash from Operations | 1.10B | 1.97B | 6.31B | 3.92B | 1.95B |
| Capital Expenditure | -347.00M | -370.00M | -320.00M | -361.00M | -260.00M |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -65.00M | -1.71B | -1.87B | -285.00M | -78.00M |
| Divestitures | 312.00M | 279.00M | 279.00M | 270.00M | 243.00M |
| Other Investing Activities | -31.00M | 340.00M | 213.00M | -97.00M | -404.00M |
| Cash from Investing | -131.00M | -1.46B | -1.70B | -473.00M | -499.00M |
| Total Debt Issued | 321.00M | 5.33B | 5.00M | 58.00M | 368.00M |
| Total Debt Repaid | -500.00M | -10.07B | -229.00M | -643.00M | -- |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -1.28B | -1.26B | -1.26B | -1.26B | -1.26B |
| Other Financing Activities | -98.00M | -33.00M | -3.00M | 11.00M | -103.00M |
| Cash from Financing | -1.56B | -6.03B | -1.49B | -1.84B | -993.00M |
| Foreign Exchange rate Adjustments | -48.00M | 5.00M | -4.00M | 128.00M | 66.00M |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -635.00M | -5.51B | 3.12B | 1.74B | 528.00M |